VERACYTE INC's ticker is VCYT and the CUSIP is 92337F107. A total of 235 filers reported holding VERACYTE INC in Q1 2021. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $191,435 | +2.5% | 8,573 | +16.9% | 0.00% | 0.0% |
| Q2 2023 | $186,797 | +38.1% | 7,334 | +20.9% | 0.00% | 0.0% |
| Q1 2023 | $135,250 | +6.2% | 6,065 | +13.0% | 0.00% | 0.0% |
| Q4 2022 | $127,335 | +102.1% | 5,366 | +40.7% | 0.00% | – |
| Q3 2022 | $63,000 | +21.2% | 3,815 | +47.0% | 0.00% | – |
| Q2 2022 | $52,000 | +36.8% | 2,596 | +90.3% | 0.00% | – |
| Q1 2022 | $38,000 | -9.5% | 1,364 | +34.9% | 0.00% | – |
| Q4 2021 | $42,000 | -6.7% | 1,011 | +4.8% | 0.00% | – |
| Q3 2021 | $45,000 | +15.4% | 965 | 0.0% | 0.00% | – |
| Q2 2021 | $39,000 | -25.0% | 965 | 0.0% | 0.00% | – |
| Q1 2021 | $52,000 | +10.6% | 965 | 0.0% | 0.00% | – |
| Q4 2020 | $47,000 | 0.0% | 965 | -33.4% | 0.00% | – |
| Q3 2020 | $47,000 | +23.7% | 1,450 | 0.0% | 0.00% | – |
| Q2 2020 | $38,000 | +8.6% | 1,450 | 0.0% | 0.00% | – |
| Q1 2020 | $35,000 | +9.4% | 1,450 | +26.1% | 0.00% | – |
| Q4 2019 | $32,000 | – | 1,150 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PERKINS CAPITAL MANAGEMENT INC | 121,880 | $2,718 | 2.56% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 209,653 | $4,675,262 | 1.93% |
| EFG Asset Management (North America) Corp. | 270,772 | $6,032,800 | 1.33% |
| ARK Investment Management | 8,409,106 | $187,523,064 | 1.29% |
| Nikko Asset Management Americas, Inc. | 3,293,645 | $72,130,826 | 0.83% |
| CLOUGH CAPITAL PARTNERS L P | 339,978 | $7,581,509 | 0.82% |
| Granahan Investment Management | 1,145,527 | $25,545,252 | 0.78% |
| OBERWEIS ASSET MANAGEMENT INC/ | 212,180 | $4,731,614 | 0.73% |
| Parkman Healthcare Partners LLC | 118,622 | $2,645,271 | 0.58% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 173,717 | $3,873,889 | 0.56% |